Related Experiment Video
Updated: Feb 10, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
Resveratrol inhibits glioma cell growth via targeting LRIG1
Lianfang Liu1, Yonghua Zhang, Kai Zhu
1Department of Oncology, Zhangjiagang Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Chinese Medicine, Jiangsu 215600, China.
Purpose:
To investigate the effect of resveratrol on the expression of leucine repeat immunoglobulin-like protein 1 (LRIG1) in glioma cell line U251 and the relationship between LRIG1 and U251 cell proliferation and apoptosis, so as to clarify other molecular mechanisms of resveratrol and look for possible new targets for the treatment of this condition.
Methods:
U251 cells were treated with 100μM resveratrol for 48 hrs. Reverse transcription- polymerase chain reaction (RT-PCR) and Western blotting were used to detect the LRIG1 level in glioma cell line U251 and the expressions of related factors after resveratrol treatment. The loss-of-function assay was performed via transfection of LRIG1 small interference and the proliferation and apoptosis of U251 cells in each group were detected via MTT assay and flow cytometry.
Results:
The mRNA and protein expression levels of LRIG1 in U251 cells were up-regulated after resveratrol treatment, accompanied with decreased Epidermal Growth Factor Receptor (EGFR). MTT assay showed that the cell proliferation rate was decreased after resveratrol treatment, and flow cytometry showed that cell apoptosis was increased. The loss-of-function assay via transfection of LRIG1 small interference showed that resveratrol could reverse the increased cell proliferation and decreased apoptosis induced by LRIG1 small interference.
Conclusions:
Resveratrol can inhibit the growth and proliferation of glioma and promote its apoptosis through upregulating the LRIG1 gene expression, which plays the effect of antiglioma growth, revealing that LRIG1 is a new biological target of resveratrol in antiglioma cell proliferation and growth.
Insights
Resveratrol boosts leucine repeat immunoglobulin-like protein 1 (LRIG1) in glioma cells, inhibiting growth and promoting apoptosis. This highlights LRIG1 as a potential target for glioma treatment.
Area of Science:
- Neuroscience
- Molecular Biology
- Oncology
Background:
- Glioma is a primary brain tumor with limited treatment options.
- Resveratrol, a natural polyphenol, exhibits anti-cancer properties.
- Leucine repeat immunoglobulin-like protein 1 (LRIG1) is implicated in cell growth regulation.
Purpose of the Study:
- To investigate resveratrol's effect on LRIG1 expression in U251 glioma cells.
- To determine the relationship between LRIG1 and glioma cell proliferation and apoptosis.
- To identify potential new therapeutic targets for glioma treatment.
Main Methods:
- U251 glioma cells were treated with resveratrol.
- Reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting assessed LRIG1 and related factor expression.
- Loss-of-function assays, MTT assays, and flow cytometry evaluated cell proliferation and apoptosis.
Main Results:
- Resveratrol upregulated LRIG1 mRNA and protein expression in U251 cells.
- Resveratrol treatment decreased cell proliferation and increased apoptosis.
- LRIG1 small interference reversed resveratrol's effects on proliferation and apoptosis.
Conclusions:
- Resveratrol inhibits glioma growth and proliferation by upregulating LRIG1.
- LRIG1 acts as an anti-glioma growth factor.
- LRIG1 represents a novel biological target for resveratrol in glioma therapy.
Related Concept Videos
Feedback Inhibition
Enzyme Inhibition
Primary and Secondary Growth in Roots and Shoots
Cells Coordinate Growth and Proliferation
Population Growth
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

